|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human DNA dC->dU-editing enzyme APOBEC-3F (aa 1-373) |
| APOBEC3F Swiss Prot# | | Q8IUX4 |
| APOBEC3F Protein names | | DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) |
| APOBEC3F Gene names | | APOBEC3F |
| Organism | | Human |
| APOBEC3F Entry name | | ABC3F_HUMAN |
| APOBEC3F Codon optimized cDNA(gene) Clone |
| APOBEC3F Cat # | | RPW0084 |
| Tag | | APOBEC3F contains A 6x histidine tag |
| APOBEC3F Formulation | | Liquid |
| APOBEC3F Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| APOBEC3F Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant APOBEC3F Protein |
| APOBEC3F Cat # | | PW0084 |
| APOBEC3F Source | | recombinant |
| APOBEC3F Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| APOBEC3F Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| APOBEC3F Activity | | N/A |
| Tag | | APOBEC3F Contains A 6x histidine tag |
| APOBEC3F Formulation | | Liquid |
| APOBEC3F Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant APOBEC3F Products | | For pricing and availability Click Here >>> |
| APOBEC3F family | | Cytidine and deoxycytidylate deaminase family |
| APOBEC3F Subcellular locations | | - |
| APOBEC3F FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: After being packaged into HIV-1 virions, blocks productive infection by massively editing dC residues to dU on the DNA minus strand during reverse transcription. The editing of the minus strand DNA of HIV-1 during reverse transcription leads to G-to-A transitions in the plus strand. The inhibition of viral replication is either due to the degradation of the minus strand before its integration or to the lethality of the hypermutations. |
| APOBEC3F Sequence | | DDBJ | EMBL | GenBank |
| APOBEC3F 3D structure | | ModBase |
| APOBEC3F interaction | | STRING |
| APOBEC3F Proteomic | | PRIDE |
| APOBEC3F Genome annotation | | Ensembl | GeneID | KEGG | UCSC |
| APOBEC3F Organism specific | | CTD | MGI |
| APOBEC3F Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| APOBEC3F Gene expression | | Bgee | ArrayExpress | Genevestigator |
| APOBEC3F Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |